We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Vienna, Austria

ESTRO 2025

Session

Monday
May 05
10:30 - 11:33
Plenary Hall
Top clinical trials
Anna Kirby, United Kingdom;
Icro Meattini, Italy
Proffered Papers
Clinical
GI / Urology
10:30 - 10:39
Focal boost to the intraprostatic tumor for intermediate and high risk prostate cancer: 10-year results of the FLAME-trial
Karolina Menne - Guricova, The Netherlands
E25-1527
10:39 - 10:48
Nivolumab plus chemoradiotherapy in patients with muscle-invasive bladder: final results of a phase II, randomized study by the HGUCG (NCT03993249).
Andromachi Kougioumtzopoulou, Greece
E25-4554
10:48 - 10:55
Discussant
Barbara Alicja Jereczek-Fossa, Italy
10:57 - 11:06
ARISTOTLE: Mature results of a phase 3 trial evaluating the addition of irinotecan to capecitabine chemoradiation in locally advanced rectal cancer
David Sebag-Montefore, United Kingdom
E25-2186
11:06 - 11:15
Organ preservation and quality of life after TNT for locally advanced rectal cancer: a study of the German Rectal Cancer Study Group (CAO/ARO/AIO-16)
Cihan Gani, Germany
E25-1735
11:15 - 11:24
Chemoradiation and IGBT Alone or in combination with Protein Kinase inhibitor in Stage III Cervical cancer: Results for Phase III Randomized trial.
Supriya Chopra, India
E25-928
11:24 - 11:34
Discussant
Panagiotis Balermpas, Switzerland